RxDoctor Payments Data

Sarah Kelly

Nurse Practitioner · Hattiesburg, MSNPI 1659507564

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.7% of the total across 359 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 28 manufacturers reported payments, led by AbbVie at 34.6% of the total. Reporting peaked in 2022 at $1,563 and has fallen 64.9% since, to $549 in 2025. Among nurse practitioner clinicians in MS with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,111in general payments, 2019–2025

Across 359 payments — averaging $14.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Novartis$1K
  • Amgen$276
  • Johnson & Johnson$180
  • LEO Pharma Inc.$179
  • Incyte Corporation$165
  • plus $1K from 22 others

What the payments were for

  • Food & beverage$5,098100%
  • Education$130%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,111 in reported general payments places this provider in the 90th percentile of 1,090 nurse practitioner providers in Mississippi.

See all nurse practitioner providers in Mississippi

Medicare billing

Part B allowed, 2024
$188,341
Medicare patients
420
Services billed
5,032

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab21$192,202
CiclopiroxCiclopirox Olamine152$4,231
Betamethasone Valerate71$2,868
Tacrolimus12$1,711
Triamcinolone Acetonide139$1,669
Fluocinonide28$1,570
Ketoconazole61$1,452
Clotrimazole71$1,066
Metronidazole18$988
Imiquimod37$947
Ammonium Lactate32$624
Doxycycline Monohydrate48$559
Doxycycline Hyclate28$444
Mupirocin42$396
Mometasone Furoate13$275

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Hattiesburg

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →